Lingli Dong
Huazhong University of Science and Technology
Internal medicineAntibodyAdverse effectRheumatologyImmunologyArthritisTocilizumabAnkylosing spondylitisBASDAIRheumatoid arthritisHydroxychloroquineDiseaseSphingomyelin synthaseIgG4-related diseaseBASFIPathogenesisMedicineBiologyImmune systemGastroenterology
50Publications
16H-index
1,066Citations
Publications 46
Newest
#1Peng HuH-Index: 2
#2Bingxia MingH-Index: 5
Last. Lingli DongH-Index: 2
view all 11 authors...
Source
#1Shaozhe Cai (HUST: Huazhong University of Science and Technology)H-Index: 3
#2Wei Sun (HUST: Huazhong University of Science and Technology)H-Index: 1
Last. Lingli Dong (HUST: Huazhong University of Science and Technology)H-Index: 16
view all 4 authors...
Source
#1Wei Zhang (Peking Union Medical College Hospital)H-Index: 1
#2Lingli Dong (HUST: Huazhong University of Science and Technology)H-Index: 16
Last. Shengyu Zhang (Peking Union Medical College Hospital)H-Index: 2
view all 7 authors...
IgG4 related disease (IgG4-RD) is an immune medicated rare disease, characterized with chronic inflammation and fibrosis in the involved organs, it is a systemic disease affected nearly every anatomic site of the body, usually involvement of multiple organs, and with diverse clinical manifestations. Due to the the relative novelty of the disease and under-recognition, the overall level of diagnosis and treatment in China is uneven. Till now, there is no relevant expert consensus or guidance of I...
Source
#1Cong Ye (HUST: Huazhong University of Science and Technology)H-Index: 6
#2Jixin Zhong (HUST: Huazhong University of Science and Technology)H-Index: 29
Last. Lingli Dong (HUST: Huazhong University of Science and Technology)H-Index: 16
view all 26 authors...
Source
#1Jinmei Su (Peking Union Medical College Hospital)H-Index: 9
#2Mengtao Li (Peking Union Medical College Hospital)H-Index: 23
Last. Xiaofeng Zeng (Peking Union Medical College Hospital)H-Index: 28
view all 30 authors...
Source
#1Lingli Dong (HUST: Huazhong University of Science and Technology)H-Index: 16
#2Anbin Huang (HUST: Huazhong University of Science and Technology)H-Index: 1
Last. Fei XiaoH-Index: 1
view all 10 authors...
Source
#1Shaozhe CaiH-Index: 3
#2Yu Chen (HUST: Huazhong University of Science and Technology)H-Index: 5
Last. Lingli DongH-Index: 16
view all 6 authors...
1 CitationsSource
#1Yu Chen (HUST: Huazhong University of Science and Technology)H-Index: 5
#1Yu Chen (HUST: Huazhong University of Science and Technology)H-Index: 18
Last. Lingli Dong (HUST: Huazhong University of Science and Technology)H-Index: 16
view all 5 authors...
Objective IgG4-related disease (IgG4-RD) is an immune-mediated multi-organ, chronic and progressive disease. Therefore, we conducted a study to investigate the susceptibility of COVID-19 in IgG4-RD patients in Hubei province, and to characterize the clinical manifestation of COVID-19 in IgG4-RD patients. Methods A follow-up system that includes over 200 IgG4-RD patients across the country during the past ten years. A total of ninety-one patients with IgG4-RD who live in Hubei, China were identif...
2 CitationsSource
#1Jixin Zhong (HUST: Huazhong University of Science and Technology)H-Index: 29
#2Cong Ye (HUST: Huazhong University of Science and Technology)H-Index: 6
Last. Lingli Dong (HUST: Huazhong University of Science and Technology)H-Index: 16
view all 4 authors...
We appreciate the valuable comments from Chen et al on our recent study about the clinical characteristics of COVID-19 cases with rheumatic disease.1 They highlight an important point about the sample size of patients with rheumatism infected with COVID-19 in our study. We agree that the sample size was relatively small, although we have included all such cases in Tongji Hospital, the hospital that admitted the most patients with COVID-19 in China. We acknowledged this limitation in the discussi...
Source
#1Jixin Zhong (HUST: Huazhong University of Science and Technology)H-Index: 29
#2Lingli Dong (HUST: Huazhong University of Science and Technology)H-Index: 16
We thank Dr. Wan and colleagues for their comments on our manuscript reporting the clinical features of COVID-19 pneumonia in patients with rheumatic disease.1 Wan et al analysed 569 cases of COVID-19 in Sarawak, Malaysia and found 4 patients with rheumatic diseases (2 systemic lupus erythematosus, 1 dermatomyositis, and 1 scleroderma). Among these four patients with COVID-19 and rheumatic disease, they noted one case requiring ventilation (25%, 1/4) and one case developing an SLE flare at admis...
Source